Primary aldosteronism and metabolic syndrome

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Metabolic Disorders

Background:

• Hypertension often coexists with metabolic risk factors like abdominal obesity, dyslipidemia, and impaired glucose homeostasis.
• Metabolic syndrome, a cluster of these factors, signifies elevated cardiovascular risk.
• Primary aldosteronism is increasingly recognized for its association with metabolic dysfunction beyond hypertension.

Purpose of the Study:

• To review the prevalence and characteristics of metabolic syndrome in primary aldosteronism.
• To explore the pathophysiological links between aldosterone and metabolic components, excluding hypertension.
• To investigate the role of aldosterone in glucose metabolism and insulin resistance.

Main Methods:

• Literature review of current knowledge on metabolic syndrome in primary aldosteronism.
• Analysis of potential pathophysiological mechanisms linking aldosterone to metabolic dysfunction.
• Discussion of contributing factors to insulin resistance and their tissue-specific effects.

Main Results:

• Metabolic syndrome is prevalent in primary aldosteronism, contributing to a high cardiovascular risk profile.
• Aldosterone overproduction is strongly linked to abnormal glucose metabolism and insulin resistance, key drivers of metabolic dysfunction.
• Potential roles of environmental factors and extra-adipose tissues in insulin resistance are considered.

Conclusions:

• Primary aldosteronism is associated with a high prevalence of metabolic syndrome, potentially explaining increased cardiovascular events.
• Further research with larger studies is needed to confirm the regression of metabolic complications after treating aldosterone excess.
• Investigating agents that correct metabolic abnormalities could offer new therapeutic avenues for primary aldosteronism.